HIGHLIGHTS
- who: Alexey V. Danilov and collaborators from the Knight Cancer Institute, Oregon Health and Science University, Portland, OR, US Service des Maladies du Sang, CHU Lille, Lille, France have published the Article: Phase 1b Study of Tirabrutinib in Combination With Idelalisib or Entospletinib in Previously Treated Chronic Lymphocytic Leukemia, in the Journal: (JOURNAL) of February/21,/2019
- what: The authors evaluated the safety, tolerability, and preliminary efficacy of the combinations TIRA/IDELA and TIRA/ENTO, as well as TIRA monotherapy, in patients with relapsed/refractory CLL.
- how: This study was conducted in accordance . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.